Urinary Tract Infection Testing Market Size, Share, Growth Analysis, By Infection Type(Urethritis, Cystitis, and Pyelonephritis), By Test Type(Urinalysis, Urine Cultures, Susceptibility Testing), By End-user(Hospitals, Diagnostic Laboratories, Research Institutes), By Test Kit(Home Test Kits, Laboratory Test Kits), By Region - Industry Forecast 2024-2031

Global Urinary Tract Infection Testing Market size was valued at USD 8.7 billion in 2022 and is poised to grow from USD 9.06 billion in 2023 to USD 12.49 billion by 2031, growing at a CAGR of 4.1% in the forecast period (2024- 2031).

The global urinary tract infection (UTI) testing market continues to evolve with advancements in diagnostic technologies and growing awareness about urinary tract infections. UTIs are common bacterial infections that affect millions of individuals worldwide, primarily women. The market for UTI testing is driven by factors such as the rising prevalence of UTIs, increasing healthcare expenditure, and a growing geriatric population susceptible to these infections. Rapid technological innovations have led to the development of accurate and efficient diagnostic tools, including point-of-care tests and non-invasive methods, enhancing the early detection and management of UTIs. Moreover, the shift towards personalized and preventive healthcare has prompted healthcare providers to adopt sophisticated diagnostic solutions, thereby boosting the demand for UTI testing products. However, challenges related to the accuracy of certain testing methods and the availability of alternative treatments might slightly restrain market growth. As the healthcare sector continues to prioritize infection management, the UTI testing market is anticipated to witness steady growth in the coming years.

US Urinary Tract Infection Testing Market is poised to grow at a sustainable CAGR for the next forecast year.